Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Blood Advances
|
April 9, 2026
Growth and puberty in African children with sickle cell anemia treated with hydroxyurea
Philippe Backeljauw, George Tomlinson, Luke R Smart, et al.
World Neurosurgery
|
June 1, 2017
Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines
Luke R Smart, Halinder S Mangat, Benson Issarow, et al.
American Journal of Hematology
|
February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial
Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Haematology
|
July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia
Charles T Quinn, Omar Niss, Min Dong, et al.
Blood
|
November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Peter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
British Journal of Haematology
|
October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa
Catherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica
|
August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa
Luke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Blood Advances
|
April 9, 2026
Growth and puberty in African children with sickle cell anemia treated with hydroxyurea
Philippe Backeljauw, George Tomlinson, Luke R Smart, et al.
World Neurosurgery
|
June 1, 2017
Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines
Luke R Smart, Halinder S Mangat, Benson Issarow, et al.
American Journal of Hematology
|
February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial
Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Haematology
|
July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia
Charles T Quinn, Omar Niss, Min Dong, et al.
Blood
|
November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Peter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
British Journal of Haematology
|
October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa
Catherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica
|
August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa
Luke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Page
of 5